UnitedHealth Group (NYSE:UNH) had its target price hoisted by Deutsche Bank to $260.00 in a research report report published on Wednesday. They currently have a buy rating on the healthcare conglomerate’s stock.
A number of other research analysts have also issued reports on the company. Citigroup lifted their target price on UnitedHealth Group from $235.00 to $268.00 and gave the stock a buy rating in a report on Wednesday. BMO Capital Markets lifted their target price on UnitedHealth Group from $14.50 to $275.00 and gave the stock an outperform rating in a report on Wednesday. Royal Bank of Canada lifted their target price on UnitedHealth Group from $269.00 to $280.00 and gave the stock an outperform rating in a report on Wednesday. Piper Jaffray Companies reaffirmed a buy rating and set a $259.00 target price on shares of UnitedHealth Group in a report on Wednesday. Finally, Cantor Fitzgerald reaffirmed a buy rating and set a $235.00 target price on shares of UnitedHealth Group in a report on Tuesday, January 16th. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group has an average rating of Buy and an average price target of $243.22.
UnitedHealth Group (UNH) opened at $243.35 on Wednesday. The stock has a market capitalization of $235,822.70, a PE ratio of 24.14, a P/E/G ratio of 1.42 and a beta of 0.66. UnitedHealth Group has a fifty-two week low of $156.49 and a fifty-two week high of $244.35. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.
In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders sold a total of 33,655 shares of company stock valued at $7,469,083 in the last quarter. 0.89% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in UNH. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $110,000. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $121,000. Finally, Acrospire Investment Management LLC boosted its position in UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the period. Hedge funds and other institutional investors own 86.09% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.